Code of Maryland Regulations (Last Updated: April 6, 2021) |
Title 10. Maryland Department of Health |
Part 5. |
Subtitle 52. PREVENTIVE MEDICINE |
Chapter 10.52.01. Opioid-Associated Disease Prevention and Outreach Programs |
Sec. 10.52.01.07. Monitoring and Evaluation
-
A. OADPO programs shall:
(1) Submit all data for each reporting period on a quarterly basis as required by the Department, including:
(a) The number of:
(i) Participants served by the OADPO program;
(ii) New participants registered by the OADPO program;
(b) Demographic data of participants served by the OADPO program, including:
(i) Age;
(ii) Gender identity;
(iii) Sexual orientation;
(iv) Race;
(v) Ethnicity;
(vi) Zip code; and
(vii) Types of drugs the participant reports using;
(c) The number of hypodermic needles and syringes distributed and collected;
(d) Each location where hypodermic needles and syringes were distributed; and
(e) The number of referrals to services provided to participants listed in Health-General Article, §24-903(A)(6), Annotated Code of Maryland, and Regulation .05A(4) of this chapter; and
(2) Collect data using methods that will not deter participants from utilizing OADPO program services.
B. The Department may conduct site visits to monitor and evaluate an OADPO program.